Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206 (Q33813718)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206 |
scientific article |
Statements
Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206 (English)
Brian I Rini
Jonathan E Rosenberg
Walter M Stadler
Daniel A Vaena
Laura Archer
James N Atkins
Joel Picus
Piotr Czaykowski
Eric J Small
5 April 2010
1 reference
1 reference
1 reference
1 reference